Inscrição YC de Rosebud Biosciences

Winter 2022Active

Rosebud Biosciences passou pela Y Combinator no batch Winter 2022 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Winter 2022
Indústria: HealthcareDrug Discovery and Delivery
Tamanho da equipe: 3
Status: Active
Lançada: 2022

Fundadores

Kitch WilsonFounder
Evan LyallFounder

O que Rosebud Biosciences faz

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Inscrição YC de Rosebud Biosciences, reconstruída

Inscrição Y Combinator

Rosebud Biosciences, lote Winter 2022. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rosebud Biosciences

Describe what your company does in 50 characters or less.

Growing micro-organs to find new drugs

What is your company going to make? Please describe your product and what it does or will do.

We grow organoids with the patients' exact gene mutations to test drugs directly on tissue models that behave like fetal organs. Our platform lets us screen drugs for rare diseases, especially pediatric conditions without treatments. It helps partners find drug candidates faster by using more accurate disease models than standard cell lines or animal models.

Where do you live now, and where would the company be based after YC?

We're based in San Francisco and San Carlos, CA. After YC, we'll stay in the Bay Area to stay close to collaborators and biotech talent.

Explain your decision regarding location.

We want to be near key research institutions and pharma partners, and both of us are already based in the Bay Area. It's where organoid research and biotech venture capital mix best.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Rosebud Biosciences?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Rosebud Biosciences (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Rosebud Biosciences se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Rosebud Biosciences esteve?

Rosebud Biosciences fez parte do batch Winter 2022 da Y Combinator.

Quem fundou o Rosebud Biosciences?

O Rosebud Biosciences foi fundado por Kitch Wilson, Evan Lyall.

O que o Rosebud Biosciences faz?

Growing micro-organs to find new drugs

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Rosebud Biosciences, e de todos os outros lotes do YC, está no YC Insights.